Diet in the management of type 2 diabetes: umbrella review of systematic reviews with meta-analyses
of randomised controlled trials - PMC Back to Top Skip to main content NIH NLM Logo Access …

Dyslipidemia is a treatable risk factor for atherosclerotic cardiovascular disease that can be
addressed through lifestyle changes and/or lipid-lowering therapies. Adherence to statins …

Metabolic syndrome (MetS) has become an increasing global health problem, which leads
to cardiovascular diseases and type 2 diabetes. Silybum marianum extracts have been …

It has been suggested that silymarin (SIL) supplementation has positive effects on
cardiovascular health and reduces the risk of cardiometabolic syndrome (CMS). This …

Diabetes is a metabolic disease affecting many tissues and organs. The main etiological
factor for diabetic complications is hyperglycemia and subsequent pathologies, such as …

Acute alcoholic liver injury (AALI) is hard to diagnose on account of no obvious clinical
symptoms, and thereby it easily develops into serious liver diseases and threatens people's …

Metabolic syndrome (MetS) is a prevalent health condition that requires significant attention
and intervention due to its multifaceted nature. It encompasses a variety of ailments such as …

Dyslipidemia is a treatable risk factor for atherosclerotic cardiovascular disease that can be
addressed through lifestyle changes and/or lipid-lowering therapies. Adherence to statins …

Chronic hyperglycemia is one of the most important causes of the formation of oxygen-free
radicals in diabetes, which damage various organs. Damage to proteins and lipids in the …

Objective: The aims of this study were to evaluate the impact of a 6-month weight loss
program (Weight Loss Maintenance 3 Phases Program-WLM3P) on clinically significant …